SEARCH RESULTS FOR: "Tag: NASDAQ-GILD"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(3)
CATEGORIES
Stocks On the Move(2)
Technical Analysis(1)

5/2/2018 3:22 PM
The Nasdaq is outperforming today, thanks to a positive earnings reaction for Apple (AAPL). Nevertheless, drug stocks Akorn, Inc. (NASDAQ:AKRX), Esperion Therapeutics Inc (NASDAQ:ESPR), and Gilead Sc...
2/22/2018 12:59 PM
U.S. stocks have steadily climbed today, as interest-rate hike concerns begin to die down. Dow component United Technologies Corporation (NYSE:UTX) and biotech stock Sangamo Therapeutics Inc (NASDAQ:S...
2/20/2018 12:00 PM
Late Friday, a federal judge reversed a jury order requiring Gilead Sciences, Inc. (NASDAQ:GILD) to pay Merck (MRK) $2.54 billion in a hepatitis C patent infringement case. In response, RBC hiked i...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center